SCHEMBL7112689

SCHEMBL7112689

CCCCOc1c(C)c(=O)c1=O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.40
LMNA P02545 2/20 0.40
KDM4E B2RXH2 1/20 0.40
MAPT P10636 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
THRA P10827 1/20 0.39
THRB P10828 1/20 0.39
CYP3A4 P08684 1/20 0.38
TSHR P16473 3/20 0.37
TDP1 Q9NUW8 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
ESR1 P03372 2/20 0.37
CA12 O43570 2/20 0.36
CA1 P00915 2/20 0.36
CA2 P00918 2/20 0.36
CA7 P43166 2/20 0.36
CA9 Q16790 2/20 0.36
MAPK1 P28482 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
LTA4H P09960 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Squaric Acid Dibutyl Ester SCHEMBL56180 0.86 CYP3A4 (0.44) ALDH1A1LMNAKDM4EMAPTNPSR1
SCHEMBL9809602 0.79 THRA (0.44) THRATHRBCYP3A4TSHRMAPK1
SCHEMBL14557648 0.79 LTA4H (0.41) ALDH1A1LMNAKDM4EMAPTNPSR1
SCHEMBL8646943 0.78 ALDH1A1 (0.37) ALDH1A1LMNAKDM4EMAPTNPSR1
SCHEMBL9809623 0.77 THRA (0.46) ALDH1A1LMNATHRATHRBTSHR
SCHEMBL26278001 0.77 THRA (0.46) ALDH1A1LMNATHRATHRBTSHR
SCHEMBL26278000 0.77 THRA (0.46) ALDH1A1LMNATHRATHRBTSHR
SCHEMBL9809630 0.77 THRA (0.46) ALDH1A1LMNATHRATHRBTSHR
SCHEMBL9809613 0.77 THRA (0.46) ALDH1A1LMNATHRATHRBTSHR
SCHEMBL6658770 0.77 THRA (0.46) ALDH1A1LMNATHRATHRBTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9841428-B2 Viscosity-sensitive dyes and method SETA BIOMEDICALS, LLC (US) 2017-12-12 US disclosed
US-9744245-B2 Oligosaccharide conjugates and methods of use The Secretary of State for Environment Food and Rural Affairs (GB) 2017-08-29 US disclosed
US-20170210764-A1 CYCLOBUTENEDIONE DERIVATIVE, NONAQUEOUS ELECTROLYTIC SOLUTION, AND LITHIUM ION SECONDARY BATTERY NEC CORPORATION (JP) 2017-07-27 US disclosed
US-20160091495-A1 VISCOSITY-SENSITIVE DYES AND METHOD SETA BIOMEDICALS, LLC 2016-03-31 US disclosed
US-20160067345-A1 OLIGOSACCHARIDE CONJUGATES AND METHODS OF USE THE SECRETARY OF STATE FOR ENVIRONMENT, FOOD AND RURAL AFFAIRS (GB) 2016-03-10 US disclosed
US-8940911-B2 Squarylated lactones inhibitors for bacterial biofilm formation SYRACUSE UNIVERSITY (US) 2015-01-27 US disclosed
US-20140039195-A1 Squarylated Lactones Inhibitors for Bacterial Biofilm Formation SYRACUSE UNIVERSITY (US) 2014-02-06 US disclosed
WO-2003087052-A2 DYES AND FLUORESCENT COMPOUNDS TERPETSCHNIG EWALD A (US) 2003-10-23 WO disclosed
US-6482950-B1 Squarylium compounds, and processes and intermediates for the synthesis of these compounds POLAROID CORPORATION 2002-11-19 US disclosed
US-5919950-A SYNTHESIS OF SQUARATE DYES POLAROID CORPORATION (US) 1999-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170210764-A1 CYCLOBUTENEDIONE DERIVATIVE, NONAQUEOUS ELECTROLYTIC SOLUTION, AND LITHIUM ION SECONDARY BATTERY HSD17B11, HSD17B7, HSD17B2 ALDH1A1 894/4885LMNA 2294/4885KDM4E 2582/4885
US-20160067345-A1 OLIGOSACCHARIDE CONJUGATES AND METHODS OF USE FUT6, SI, DDOST ALDH1A1 2421/4885LMNA 3295/4885KDM4E 1511/4885
US-20140039195-A1 Squarylated Lactones Inhibitors for Bacterial Biofilm Formation BPHL, MGLL, FDFT1 ALDH1A1 3229/4885LMNA 4117/4885KDM4E 2577/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.